about
Guidelines for the use and interpretation of assays for monitoring autophagyThe role of microRNAs in intrahepatic cholangiocarcinomaHULC: an oncogenic long non-coding RNA in human cancerPropofol lowers serum PF4 level and partially corrects hypercoagulopathy in endotoxemic rats.The pharmacological actions of nicotine on the gastrointestinal tract.Leptin downregulates aggrecan through the p38-ADAMST pathway in human nucleus pulposus cellsFK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells.Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells.MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degenerationDihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer.Miltirone induced mitochondrial dysfunction and ROS-dependent apoptosis in colon cancer cells.Drug Fever Induced by Piperacillin/Tazobactam in a Scoliosis Patient: A Case Report.Stratified polygenic risk prediction model with application to CAGI bipolar disorder sequencing data.The Tpeak - Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysis.Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.Leptin activates RhoA/ROCK pathway to induce cytoskeleton remodeling in nucleus pulposus cells.Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer.MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1.Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms.Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disordersCathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer.Genome-wide association and sequencing studies on colorectal cancer.The Janus face of cathelicidin in tumorigenesis.Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer.Animal models of gastrointestinal inflammation and cancer.Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review).MicroRNA expression and its clinical implications in Ewing's sarcoma.MicroRNA in intervertebral disc degeneration.MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.microRNA deregulation in keloids: an opportunity for clinical intervention?TIP30: A Novel Tumor-Suppressor Gene.The roles of microRNAs in Wilms' tumors.Warning criteria for intraoperative neurophysiologic monitoring.Role of microRNAs in primary central nervous system lymphomas.Pathological Role and Diagnostic Value of Endogenous Host Defense Peptides in Adult and Neonatal Sepsis: A Systematic Review.CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer.Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity.TUG1: a pivotal oncogenic long non-coding RNA of human cancers.
P50
Q21996341-D4EEB951-C6F0-4614-9AD6-78818DA7D11DQ28067652-22449863-FD6E-4AEA-9E14-D19CCAC0DA30Q28076430-8D955462-7252-49FC-B3B6-3505118AB54AQ33624838-2B5D451F-2E51-44A7-AE44-4B46DCE3188CQ34316232-28EF5A2A-5803-4925-BE12-CF58D7B6F7BFQ34316566-990870D2-48DF-4EAD-B0EE-5852433ACEECQ34735130-00471396-F0F4-4877-8AE1-ABCE9C4FB48DQ34842454-2C6BE43F-70E9-46DF-A7CC-41245AA84A5BQ35077900-3605989A-72EC-48AD-AAA9-44D2BFE8B1E4Q35835195-119A5D4B-9CA1-43CA-A3D6-AFDF32C8FCBAQ35954899-0E32EC3F-09F1-464C-A134-0053F5B3D861Q36299254-91FB4BF6-1792-441B-869D-2A3B5E22B4C5Q36350018-F78CB0CA-EF2B-48B7-B88F-04FB5FA34B59Q36383747-03344A0A-4362-43A8-92F4-36088C9575EAQ36761921-08D1B887-AD75-4423-82E9-09FBBB53F877Q37535611-0438E069-F7DC-404B-AFE4-7952D1E4796FQ37542610-EFAD8AF8-703E-4D16-85DF-9DCE802FC4A9Q37604355-E5753280-8E77-4FF3-B24D-B1D69B96DCC7Q37728274-9523B53C-4F3A-4375-84F8-7498D0D31501Q37777020-B242CFCE-10DA-4B7B-8648-77D8A3B2BDA9Q38107933-2F5678AE-B7DC-416F-8BAF-21A195532E16Q38149684-D4655CD9-86F9-4C52-AB4D-7B8CEFD49048Q38187723-ABEBC12E-398A-424C-BB6D-8A50EF66B5E7Q38196348-563EF331-2561-49E7-A1E8-0961E12763C9Q38211612-6B471CC1-98EF-423E-BDFE-4D1AC2BA10F3Q38214520-562A4A8F-9C19-463E-AB96-366C74EC791EQ38296481-D173CC82-A58F-4ADF-9CD0-FDBFFC51EAD3Q38367405-05700BD2-4915-48C4-821C-162B547E4CEEQ38552358-97D51D91-E57F-43F9-AA21-449466DDE75BQ38552402-6CA1BBD1-EC31-4AAF-9725-3C332944D0F3Q38612431-BD569B7C-C7F4-455E-877E-C452FC682879Q38656693-CBF452A0-541E-4A52-958A-E8A50D7AB351Q38658528-BABA707B-CC3D-46BC-816F-E8A93E883A69Q38673869-CBB7C9BE-FE36-4C98-B4D1-88BE5CB0FA22Q38779730-7750B422-C5E6-4DE1-BC5C-5E2BE1DB824BQ38784303-51B7EE7B-A515-4483-830F-D7F69A3B89D3Q38822607-33FFB333-137A-48E0-877B-FBAE2678D725Q38871707-0EE7F435-FF69-4B92-910B-0FE65E8FD835Q38873954-62EFFB5E-1022-4732-8A74-8ED63F62E57EQ38875365-1CF36312-F70E-4B7E-B1EC-B2E74A306B66
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
William Ka-Kei Wu
@ast
William Ka-Kei Wu
@en
William Ka-Kei Wu
@es
William Ka-Kei Wu
@nl
type
label
William Ka-Kei Wu
@ast
William Ka-Kei Wu
@en
William Ka-Kei Wu
@es
William Ka-Kei Wu
@nl
prefLabel
William Ka-Kei Wu
@ast
William Ka-Kei Wu
@en
William Ka-Kei Wu
@es
William Ka-Kei Wu
@nl
P108
P106
P31
P496
0000-0002-5662-5240